Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000014272-21-000118
Filing Date
2021-04-02
Accepted
2021-04-02 13:16:26
Documents
1
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_161738372741256.html 4  
1 FORM 4 wf-form4_161738372741256.xml 4 4212
  Complete submission text file 0000014272-21-000118.txt   5685
Mailing Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
Business Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
BRISTOL MYERS SQUIBB CO (Issuer) CIK: 0000014272 (see all company filings)

EIN.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address
Haller Julia A (Reporting) CIK: 0001656082 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-01136 | Film No.: 21801341